[1]王耀普,杨康健,赵思源,等.兔肝癌模型的改良接种及其DSA影像分析[J].介入放射学杂志,2010,(03):214.
 WANG Yaopu,YANG Kangjian,ZHAO Siyuan,et al.The modified inoculation method for the preparation of rabbit VX2hepatic carcinoma model and DSA imagining observation[J].journal interventional radiology,2010,(03):214.
点击复制

兔肝癌模型的改良接种及其DSA影像分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年03期
页码:
214
栏目:
实验研究
出版日期:
2010-03-15

文章信息/Info

Title:
The modified inoculation method for the preparation of rabbit VX2hepatic carcinoma model and DSA imagining observation
作者:
王耀普杨康健赵思源
044000山西省运城市中心医院导管室(王耀普);第四军医大学唐都医院介入放射科(杨康健、赵思源、赵斌羽、曹玮、李超、杨清峰、王执民、张洪新)
Author(s):
WANG Yao-puYANG Kang-jianZHAO Si-yuanZHAO Bin-yuCAO WeiLI ChaoYANG Qing-fengWANG Zhi-minZHANG Hong-xin.
Tangdu Hospital,Fourth Military Medical University of Chinese PLA,Xi ’an,Shaanxi Province710038,China
关键词:
肝癌兔Vx2细胞株数字减影成像
分类号:
R735.7
文献标志码:
B
摘要:
目的建立可供实验研究稳定的兔Vx2移植性肝癌模型,探讨不同植瘤方式的成功率,并分析该肿瘤的DSA影像特征。方法60只新西兰白兔随机分3组,每组20只。将Vx2瘤细胞(5×10 7 个)经肝动脉或经肝包膜分别接种于2组兔的肝左叶,建立对照肝癌模型。第3组经肝包膜植入瘤组织块(约含10 6 ~10 8 个瘤细胞)建立改良肝癌模型。观察:①不同组植瘤的成活率。②改良Vx2移植性肝癌的DSA影像特征。结果3组植瘤成活率分别为7/20、10/20、19/20,改良组植瘤成活率最高,差异有统计学意义(P<0.05)。DSA影像示该移植性肝癌具有丰富的血供。结论成功建立了兔Vx2移植性肝癌改良模型,瘤组织块种植方式成功率明显高于动脉途径和细胞液注射方式,为肝癌介入治疗的基础及临床研究提供了成熟的大型实验动物模型。

参考文献/References:

[1]严惠芳,傅文君,任文龙.可移植性动物肿瘤株的冻存和复苏[J].医药工业,1986,17:28-29.
[2]Prat F,Centarti M,Sibille A,et al.Extracorporeal high-intensity focused ultrasound for VX2liver tumors in the rabbit[J].Hepatology,1995,21:832-836.
[3]Hanahan D,Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J].Cell,1996,86:353-364.
[4]Morgon-Parkes JH.Metastases:mechanisms ,pathways,and cascades[J].AJR,1995,164:1075-1082.
[5]Swistel AJ ,Bading JR,Raaf JH.Intraarterial versus intravenous Adriamycin in the rabbit VX2tumor system[J].Cancer,1984,53:1397-1404.
[6]Girard MS ,Baker KG,Steinbach GC,et al.Assessment of liver and kidney enhancement with a perfluorocarbon vapor-stabilized US contrast agent [J].Acad Radiol,1999,6:273-281.
[7]Leander P,Mnsson S,Ege T,et al.CT and MR imaging of the liver using liver-specific contrast media.A comparative study in a tumor model[J].Acta Radiol,1996,37:242-249.
[8]Eda I,Soga H,Ueoka M,et al.The suppression of postoperative liver metastasis caused by the continuous intraportal infusion of angiogenesis inhibitor FR-118487in a rabbit colon cancer model[J].Surg Today,1998,28:273-278.
[9]Okada M,Kudo S,Miyazaki O,et al.Antitumoral efficacy and pharmacokinetic preperties of pirarubicin upon hepatic intra-arterial injection on the rabbit VX2tumor model[J].Br J Cancer,1995,71:518-524.
[10]Tanaka H,Taniguchi T,Mugitani Y,et al.Intraarterial administration of the angiogenesis inhibitor TNP-470blocks liver metastasis in a rabbit model[J].Br J Cancer,1995,72:650-653.
[11]Zhao ZX,Du JH,Wang XH,et al.Pharmacokinetic study of intraarterial hepatic pirarubicin-lipiodol administration in rabbits bearing VX2tumor[J].Chin J Exp Surg,1998,15:244-245.
[12]曹玮,万毅,张洪新,等.脉冲式温热灌注对肿瘤血管渗透性的影响[J].介入放射学杂志,2008,17:266-268.
[13]李广琪,陈毓秀,康军,等.兔肝VX2移植癌改良模型建立[J].武警医学院学报,2007,16:369-372.
[14]曹玮,彭建明,王执民,等.60℃碘油栓塞对兔肝VX2肿瘤血供的影响[J].实用放射学杂志,2008,24:837-839.
[15]曹玮,吴发伟,刘毅勇,等.高强度聚焦超声对中晚期肝癌患者机体免疫细胞及其活性的影响[J].介入放射学杂志,2009,18:308-310.

相似文献/References:

[1]曹海利,孟巍,白彬.肝癌基因治疗研究新进展[J].介入放射学杂志,2008,(05):375.
 CAO Haili,MENG Wei,BAI Bin.New progress in research of gene therapy for hepatocellular carcinoma[J].journal interventional radiology,2008,(03):375.
[2]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
 LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].journal interventional radiology,2008,(03):514.
[3]杨伟洪,刘鹏程,梁珊瑚,等.多层螺旋CT血管造影在判断肝癌寄生供血中的价值[J].介入放射学杂志,2008,(09):654.
 YANG Weihong,LIU Pengchen g,LIANG Shanhu,et al.Evaluation of MSCTA for parasitic blood supply in hepatic carcinoma[J].journal interventional radiology,2008,(03):654.
[4]张茵,周兵,许秀芳,等.肝动脉化疗栓塞治疗原发性肝癌存活20年一例[J].介入放射学杂志,2008,(09):684.
 ZHANG Yin,ZHOU Bing,XU Xiufang,et al.Survival more than20years after transarterial chemical embolization for hepatocellular carcinoma:A case report[J].journal interventional radiology,2008,(03):684.
[5]官泳松,贺庆.肝癌介入治疗中应用p53的几个要点[J].介入放射学杂志,2008,(11):761.
 GUAN Yongsong,HE Qing.Essentials in clinical application of p53for tumors intervention-example of liver cancer[J].journal interventional radiology,2008,(03):761.
[6]肖运平,肖恩华.介入治疗在防治肝癌术后复发中的作用及进展[J].介入放射学杂志,2008,(11):831.
 XIAO Yunping,XIAO Enhua.The role and progress of interventional therapy in the prevention and treatment of postoperative hepatocellular carcinoma recurrence[J].journal interventional radiology,2008,(03):831.
[7]史震山,陈自谦,杨熙章,等.原发性大肝癌患者TACE后S-腺苷蛋氨酸的护肝作用[J].介入放射学杂志,2008,(11):790.
 SHI Zhenshan,CHEN Ziqian,YANG Xizhang,et al.The clinical study on the liver-protection of S-adenosy-methionine in large hepatocellular carcinoma patients after TACE[J].journal interventional radiology,2008,(03):790.
[8]贺洪德,贺晶,罗中华,等.肝动脉化疗栓塞联合门静脉栓塞治疗中晚期肝癌的疗效评价[J].介入放射学杂志,2010,(03):191.
 HE Hongde,HE Jing,LUO Zhonghua,et al.Evaluation of the therapeutic effect of hepatic arterial chemoembolization combined with portal chemoembolization for advanced hepatic carcinomas[J].journal interventional radiology,2010,(03):191.
[9]李广琪,曹玮,李超,等.肝动脉热灌注对兔肝VX2肿瘤及正常肝组织血管渗透性功能的作用[J].介入放射学杂志,2010,(03):217.
 LI Guangqi,CAO Wei,LI Chao,et al.Influence of hepatic artery thermotherapy on the vascular permeability of hepatic tumor tissue and normal liver tissue in VX2tumor-bearing rabbits[J].journal interventional radiology,2010,(03):217.
[10]杨康健,赵思源,赵斌羽,等.兔肝癌改良接种模型的生长特性研究[J].介入放射学杂志,2010,(03):211.
 YANG Kangjian,ZHAO Siyuan,ZHAO Binyu,et al.The growing features of rabbit VX2hepatic carcinoma model prepared with modified inoculation method[J].journal interventional radiology,2010,(03):211.

备注/Memo

备注/Memo:
收稿日期:2010-02-25
更新日期/Last Update: 2010-03-15